0 NASDAQ Companies - August 5, 2020Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent HighlightsSOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing […]Read More
0 NASDAQ Companies - August 5, 2020Immunomedics Reports Second Quarter 2020 Results and Provides Corporate UpdateEncouraging early adoption of Trodelvy™ in U.S. with $20.1M net sales in first two months of launchConfirmatory Phase 3 ASCENT […]Read More
0 NASDAQ Companies - August 5, 2020MannKind Corporation Reports 2020 Second Quarter Financial Results2Q 2020 Afrezza Net Revenue of $7.0 million; +15% vs. 2Q 20191H 2020 Afrezza Net Revenue of $15.0 million; +35% […]Read More
0 NASDAQ Companies - August 5, 2020OPKO Health to Participate in BTIG Virtual Biotechnology ConferenceMIAMI, Aug. 05, 2020 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that management will participate in a […]Read More
0 NASDAQ Companies - August 5, 2020Nasdaq Welcomes BigCommerce Holdings, Inc. (Nasdaq: BIGC) to The Nasdaq Stock MarketNEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (Nasdaq: BIGC), a leading open SaaS ecommerce platform for […]Read More
0 NASDAQ Companies - August 5, 2020Glen Burnie Bancorp Announces Second Quarter 2020 ResultsGLEN BURNIE, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding company for […]Read More
0 NASDAQ Companies - August 5, 2020ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory BoardWestport, CT, Aug. 05, 2020 (GLOBE NEWSWIRE) —Dr. Sofia is an Inductee in the American Chemical Society Medicinal Chemistry Hall […]Read More
0 NASDAQ Companies - August 5, 2020Clarus’ Sierra Bullets Appoints Keith Enlow as PresidentSALT LAKE CITY, Aug. 05, 2020 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (the “Company”) subsidiary Sierra Bullets, L.L.C. (“Sierra” […]Read More
0 NASDAQ Companies - August 5, 2020Surface Oncology to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceCAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]Read More
0 NASDAQ Companies - August 5, 2020IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s DiseaseBRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of […]Read More